AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway |
Park, Jin Woo
(Department of Life Science, College of Natural Sciences, Chung-Ang University)
Cho, Hana (Department of Life Science, College of Natural Sciences, Chung-Ang University) Oh, Hyein (Department of Life Science, College of Natural Sciences, Chung-Ang University) Kim, Ji-Young (Department of Life Science, College of Natural Sciences, Chung-Ang University) Seo, Sang-Beom (Department of Life Science, College of Natural Sciences, Chung-Ang University) |
1 | Valerio, D.G., Xu, H., Chen, C.W., Hoshii, T., Eisold, M.E., Delaney, C., Cusan, M., Deshpande, A.J., Huang, C.H., Lujambio, A., et al. (2017). Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis. Cancer Res. 77, 1753-1762. DOI |
2 | van Haaften, G., Dalgliesh, G.L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J., et al. (2009). Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41, 521-523. DOI |
3 | Van Hooser, A., Goodrich, D.W., Allis, C.D., Brinkley, B.R., and Mancini, M.A. (1998). Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation. J. Cell Sci. 111 ( Pt 23), 3497-3506. |
4 | Venkataraman, S., Alimova, I., Tello, T., Harris, P.S., Knipstein, J.A., Donson, A.M., Foreman, N.K., Liu, A.K., and Vibhakar, R. (2012). Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells. J. Neurooncol. 107, 517-526. DOI |
5 | Warrell, R.P., Jr. (1999). Arsenicals and inhibitors of histone deacetylase as anticancer therapy. Haematologica 84 Suppl EHA-4, 75-77. |
6 | Zhao, W., Li, Q., Ayers, S., Gu, Y., Shi, Z., Zhu, Q., Chen, Y., Wang, H.Y., and Wang, R.F. (2013). Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination. Cell 152, 1037-1050. DOI |
7 | Zuber, J., Shi, J., Wang, E., Rappaport, A.R., Herrmann, H., Sison, E.A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011). RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524-528. DOI |
8 | Rountree, M.R., Bachman, K.E., and Baylin, S.B. (2000). DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25, 269-277. DOI |
9 | Agger, K., Cloos, P.A., Christensen, J., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., Canaani, E., Salcini, A.E., and Helin, K. (2007). UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449, 731-734. DOI |
10 | Asada, M., Yamada, T., Ichijo, H., Delia, D., Miyazono, K., Fukumuro, K., and Mizutani, S. (1999). Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18, 1223-1234. DOI |
11 | Auwerx, J. (1991). The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47, 22-31. DOI |
12 | Crosio, C., Fimia, G.M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S., Allis, C.D., and Sassone-Corsi, P. (2002). Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22, 874-885. DOI |
13 | Cantu, C., Ierardi, R., Alborelli, I., Fugazza, C., Cassinelli, L., Piconese, S., Bose, F., Ottolenghi, S., Ferrari, G., and Ronchi, A. (2011). Sox6 enhances erythroid differentiation in human erythroid progenitors. Blood 117, 3669-3679. DOI |
14 | Chang, E., Ganguly, S., Rajkhowa, T., Gocke, C.D., Levis, M., and Konig, H. (2016). The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells. Leukemia 30, 1025-1032. DOI |
15 | Chen, C.W., Koche, R.P., Sinha, A.U., Deshpande, A.J., Zhu, N., Eng, R., Doench, J.G., Xu, H., Chu, S.H., Qi, J., et al. (2015). DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia. Nat. Med. 21, 335-343. DOI |
16 | Daigle, S.R., Olhava, E.J., Therkelsen, C.A., Basavapathruni, A., Jin, L., Boriack-Sjodin, P.A., Allain, C.J., Klaus, C.R., Raimondi, A., Scott, M.P., et al. (2013). Potent inhibition of DOT1L as treatment of MLLfusion leukemia. Blood 122, 1017-1025. DOI |
17 | Fuks, F., Burgers, W.A., Brehm, A., Hughes-Davies, L., and Kouzarides, T. (2000). DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24, 88-91. DOI |
18 | Gautschi, O., Heighway, J., Mack, P.C., Purnell, P.R., Lara, P.N., Jr., and Gandara, D.R. (2008). Aurora kinases as anticancer drug targets. Clin. Cancer Res. 14, 1639-1648. DOI |
19 | Gorgun, G., Calabrese, E., Hideshima, T., Ecsedy, J., Perrone, G., Mani, M., Ikeda, H., Bianchi, G., Hu, Y., Cirstea, D., et al. (2010). A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma. Blood 115, 5202-5213. DOI |
20 | Gilan, O., Lam, E.Y., Becher, I., Lugo, D., Cannizzaro, E., Joberty, G., Ward, A., Wiese, M., Fong, C.Y., Ftouni, S., et al. (2016). Functional interdependence of BRD4 and DOT1L in MLL leukemia. Nat. Struct. Mol. Biol. 23, 673-681. DOI |
21 | Gu, J., Gong, Y., Huang, M., Lu, C., Spitz, M.R., and Wu, X. (2007). Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians. Carcinogenesis 28, 350-355. |
22 | Han, A., Chae, Y.C., Park, J.W., Kim, K.B., Kim, J.Y., and Seo, S.B. (2015). Transcriptional repression of ANGPT1 by histone H3K9 demethylase KDM3B. BMB Rep. 48, 401-406. DOI |
23 | Hendzel, M.J., Wei, Y., Mancini, M.A., Van Hooser, A., Ranalli, T., Brinkley, B.R., Bazett-Jones, D.P., and Allis, C.D. (1997). Mitosisspecific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360. DOI |
24 | Hong, S., Cho, Y.W., Yu, L.R., Yu, H., Veenstra, T.D., and Ge, K. (2007). Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc. Natl. Acad. Sci. USA 104, 18439-18444. DOI |
25 | Messeguer, X., Escudero, R., Farre, D., Nunez, O., Martinez, J., and Alba, M.M. (2002). PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333-334. DOI |
26 | Hsu, J.Y., Sun, Z.W., Li, X., Reuben, M., Tatchell, K., Bishop, D.K., Grushcow, J.M., Brame, C.J., Caldwell, J.A., Hunt, D.F., et al. (2000). Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102, 279-291. DOI |
27 | Huang, X.F., Luo, S.K., Xu, J., Li, J., Xu, D.R., Wang, L.H., Yan, M., Wang, X.R., Wan, X.B., Zheng, F.M., et al. (2008). Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia. Blood 111, 2854-2865. DOI |
28 | Kim, S.R., Kim, K.B., Chae, Y.C., Park, J.W., and Seo, S.B. (2016). H3S10 phosphorylation-mediated transcriptional regulation by Aurora kinase A. Biochem. Biophys. Res. Commun. 469, 22-28. DOI |
29 | Krivtsov, A.V., and Armstrong, S.A. (2007). MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 7, 823-833. DOI |
30 | Liu, Q., and Ruderman, J.V. (2006). Aurora A, mitotic entry, and spindle bipolarity. Proc. Natl. Acad. Sci. USA 103, 5811-5816. DOI |
31 | Meyer, C., Hofmann, J., Burmeister, T., Groger, D., Park, T.S., Emerenciano, M., Pombo de Oliveira, M., Renneville, A., Villarese, P., Macintyre, E., et al. (2013). The MLL recombinome of acute leukemias in 2013. Leukemia 27, 2165-2176. DOI |
32 | Meyer, C., Kowarz, E., Hofmann, J., Renneville, A., Zuna, J., Trka, J., Ben Abdelali, R., Macintyre, E., De Braekeleer, E., De Braekeleer, M., et al. (2009). New insights to the MLL recombinome of acute leukemias. Leukemia 23, 1490-1499. DOI |
33 | Nowak, D., Stewart, D., and Koeffler, H.P. (2009). Differentiation therapy of leukemia: 3 decades of development. Blood 113, 3655-3665. DOI |
34 | Oh, S.T., Kim, K.B., Chae, Y.C., Kang, J.Y., Hahn, Y., and Seo, S.B. (2014). H3K9 histone methyltransferase G9a-mediated transcriptional activation of p21. FEBS Lett. 588, 685-691. DOI |
35 | Ota, T., Suto, S., Katayama, H., Han, Z.B., Suzuki, F., Maeda, M., Tanino, M., Terada, Y., and Tatsuka, M. (2002). Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res. 62, 5168-5177. |
36 | Plass, C., Oakes, C., Blum, W., and Marcucci, G. (2008). Epigenetics in acute myeloid leukemia. Semin. Oncol. 35, 378-387. DOI |
37 | Smetana, K., Mikulenkova, D., and Klamova, H. (2011). Heterochromatin density (condensation) during cell differentiation and maturation using the human granulocytic lineage of chronic myeloid leukaemia as a convenient model. Folia Biol. 57, 216-221. |
38 | Sakakura, C., Hagiwara, A., Yasuoka, R., Fujita, Y., Nakanishi, M., Masuda, K., Shimomura, K., Nakamura, Y., Inazawa, J., Abe, T., et al. (2001). Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer 84, 824-831. DOI |
39 | Sehdev, V., Peng, D., Soutto, M., Washington, M.K., Revetta, F., Ecsedy, J., Zaika, A., Rau, T.T., Schneider-Stock, R., Belkhiri, A., et al. (2012). The aurora kinase A inhibitor MLN8237 enhances cisplatininduced cell death in esophageal adenocarcinoma cells. Mol. Cancer Ther. 11, 763-774. DOI |
40 | Shechter, D., Dormann, H.L., Allis, C.D., and Hake, S.B. (2007). Extraction, purification and analysis of histones. Nat. Protoc. 2, 1445-1457. DOI |
41 | Son, H.J., Kim, J.Y., Hahn, Y., and Seo, S.B. (2012). Negative regulation of JAK2 by H3K9 methyltransferase G9a in leukemia. Mol. Cell. Biol. 32, 3681-3694. DOI |
42 | Sugarman, J.L., Schonthal, A.H., and Glass, C.K. (1995). Identification of a cell-type-specific and E2F-independent mechanism for repression of cdc2 transcription. Mol. Cell. Biol. 15, 3282-3290. DOI |
43 | Tonelli, R., Sartini, R., Fronza, R., Freccero, F., Franzoni, M., Dongiovanni, D., Ballarini, M., Ferrari, S., D'Apolito, M., Di Cola, G., et al. (2006). G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent. Leukemia 20, 1307-1310. DOI |
![]() |